A significant breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This vital tumor suppressor protein is frequently disabled in several types of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research